Yves here. This post gives a useful compilation of many of the reasons why distribution of the Covid vaccines is proving to be a train wreck.
And in a colossal confirmation that lack of operational competence isn’t unique to one side of the aisle, the press is reporting tonight that Biden has decided to release all the vaccines now, rather than hold half back for the second shot. Since the logjam is in the local distribution, which is nowhere close to being remedied, doubling the amount that goes out the door will guarantee that even more vaccines will become unusable. Recall that the Pfizer vaccine, once it is shipped, can be stored in the shipping boxes with dry ice for only 30 days; it can be held for an additional 5 days at refrigerator temps. I strongly suspect that the vaccine could be stored for much longer in a super-cold freezer. But as readers discussed at length early on, there aren’t many out there and they are way too costly to justify buying enough to help with peak super cold storage needs.
One point this piece does not quite nail is that a big impediments to vaccine distribution is what amounts to complicated means testing via allowing only priority groups to get vaccinated…when some members of those groups, like retirement home employees and medical workers are turning it down in reasonable numbers. One of the more extreme examples is listed below. New York has set phases. Until it has finished vaccinating one tier, it won’t move to the next.
By Centona. Originally published at Health Care Renewal
QR: the Quarterly Report
OK, it’s probably way past time for me to get away from this old “got my dander up” thing. Seems it gets up way too often anyway. Maybe this is the last one. Caution: it runs long. For a quick read, just take in the bullet lists.
- In STM, in the mid- to late-20th century, we had moon shots and such. Mostly government run but with a huge number of private contractors. There was coordination but admittedly benefited most of all Big Government and Big Industry.
- We’ve had much more recent efforts at space exploration that morphed into true public-private collaborations. Still mostly Big Government and Big Industry.
- Preview of coming post: we’ve had barely-noticed efforts for over a quarter century to do the hard science. These efforts centered in publicly funded labs at non-profit institutions, and in a few quarters of the then-nascent biopharma industry. Without such efforts, results described in the next, fourth bullet would’ve never occurred. This quietly benefited every man, woman and child.
- Now we have those public-private efforts since early 2020: newly visible, highly laudable, efforts to produce immunization protocols for COVID-19 at “Warp Speed.” Yes, warp speed after 25 years of science. But nonetheless, remarkable. As pure science, but not as PH applied science.
- What’s been missing, throughout: attention to “the last six feet,” to the mechanisms of cooperation and health care delivery that must, in a pandemic, supersede the usual habits of mind of managerial cultures, those focusing on the quarterly report, on the latest technology, and the high margin care centered in hospitals.
1. Universal healthcare. “Community services are ubiquitous in Israel.”
But wait! Even those in the US who do have insurance, and access to most services, can’t get vaccinated and don’t know when they will. The continuum-of-care clearly creates momentum. But people all over the US are busting their buns trying to participate. They’re waiting for dozens of hours in snaking lines.
Seems we can reach out to individuals, but not to populations.
But wait! Even those who trust their physicians—despite what you may have read,most Americans of all ethnicities do, at least those with personal physicians—can’t get to the doses. The doses are being heavily guard-railed to protect those giving them against accusations of…what? Unfairness. Queue-jumping. Just being overwhelmed.
OK, I buy this one. It would be hypocritical to criticize our margin-, QR-, and fractionated care-oriented health system and not buy the importance of the tilt-to-prevention effect.
But wait: didn’t we used to know how to mobilize? Can you spell “NDMA”? Um, no. But maybe Uncle Joe can.
But wait! Don’t we have a huge medical workforce? I bet it’s bigger per capita than Israel’s. Don’t we have a NDMA? In any case the actual OECD numbers tell a different story. Israel has a middling number of doctors (3.1) per thousand inhabitants, while the US has a slightly lower (2.6) number. For nurses, the other way around, our 11.9 to Israel’s 5.0. The real story, therefore, likely resides in how all these personnel are actually deployed. (And for workforce redeployment, long lead times are admittedly needed, even with the right financial incentives.)
Fact is, nonetheless: the vaccine lines could have delivered far more doses per hour and arms per vial if managers had just temporarily redeployed personnel instead of making sure high-margin services didn’t suffer at hospitals who got the vaccine. Managers do three things really well: protect the brand. Control the message. Amp the quarterly report. Non-profits, same as for-profits.
It’s the NIMBY effect. “We can’t run the {fill in the blank} if you take all our nurses.” (I paraphrase.) But don’t exaggerate. Take a few from each site, be fair, spread the pain, get shots in arms. We could’ve already done this.
But wait! Like the guy on the exhibit-hall floor at the auto show, “yeah, we got that.” Roll up a refrigerated truck, boys. Community-based delivery site have largely if not entirely been left out. They shouldn’t have.
“We run vaccination campaigns all the time,” [one nurse] said. “We do it every winter.”But wait! We do it too. Why aren’t CVS and others already putting doses in arms right now? Money, you say? This really sounds like special pleading after the many billions spent on getting the vaccine developed. It’s quite simply, even at the local and state levels, managerial incompetence. How else to explain that at fancy places like Stanford, interns, residents and respiratory therapists got the shaft while “orthopedic surgeons, nurses treating outpatients, and a dermatologist [were vaccinated]?” This absurdity was replicated all over the country.What a colossal piece of mismanagement. Maldistribution, non-planning, and waste. More on that in the final two sections of this posting.
Wait, what!?! For decades, major legislation, in the military, at the VA, and for at least two decades in the civilian sector we’ve had enormous investment in digitization of records. Admittedly the EHR too has been far too fractionated, as Dr. Scot Silverstein and others have written in this blog, as have others. But technology, or rather lack thereof, is not the reason we’ve blown it.
But wait: we just spent almost a billion dollars on media campaigns for one run-off election in one state. That would buy a whole lot of trucks carrying ultra-cold refrigerators. In the meantime the “commuication” goal is more about getting above the 70% uptake level than it is about getting shots into arms based on available doses. (New York State currently has an anemic but attractive such advertising effort, a start). It’s not like we’ve got people in miles-long lines chickening out at the last minute. What’s happening at the last minute is that, where they’re allowed to queue up based on age, people over a certain age are getting turned away at the door after hours-long waits.
But wait: hogwash! There’s nothing wrong with the American people, who’re rapidly coming around to the realization this is a ticket back to their old lives. We’ll have plenty more to say about anti-vaccinationism (are you listening Robert Kennedy?) in a coming blog. Meantime, one can only say hogwash: it’s not the people. It’s the leadership. Again, not just national but local and everything in-between.
The USA.
In the US, we’re all over the map. But some data points stand out.
- Comorbidities have been down-graded in importance. “Too complex.” (I don’t buy that.) Age has largely become a surrogate for comorbidity. I can actually argue this one both ways.
- At least two physicians in my respondent group, one in California and one in Pennsylvania, are immunocompromised and have been denied even a place on the schedule. The given reason, interestingly, was not that immune status is unimportant. Rather, these physicians are community-based with no longer active hospital affiliations. So: no hospital to resort to for access to the jab. As of today, 1% of Californians have received immunization—unclear if this is a first injection or whole series. Hunch: the former.
- In Tennessee, rightly we think, the elderly have been given opportunities to sign on and get early vaccination. The chosen cut-point was 75 and older. In some counties the schedules already run out to February, but at least folks can plan. One site to which 75 year old people were invited filled its schedule in two hours. Its county seat mayor “criticized the state for lack of a coordinated response or effective communication throughout the pandemic.” Meanwhile this state is just full of contradictions: in one hospital, Saint Thomas Rutherford, it seems fully 60% of the medical staff is refusing the vaccine. Maybe this is why the powers-that-be are opening it up to non-immunocompromised, non-institutionalized elders. Also looks as though more responsibility has been already been given to CVS-like entities, e.g. Walgreens in Tennessee. Some sources say large pharmacy chains will play a larger part outside the crowded east coast.
- (We know, admittedly if only from the media—no professional informants here—that Florida got a gubernatorial thumb-on-the-scale for its old folks. Whoops. They’ve been lining up and camping out overnight, then turned away. I’ll try to update this if I get real numbers. Otherwise, it’s just murky and a predictable if confusing result of the old GOP thumb-on-the-scale.)
- In Colorado, the state university’s health system and Kaiser shoulder a lot of the burden. Seniors aged 70 and higher are in a high category and either are being, or soon will be, lining up for the jab. Respondents in this state think 70+ year old citizens will be brought in somewhere around February—maybe. “Watch your social media.” On the other hands, we’re told by some informants on a conference call, health providers in Ohio are even worse off than those in Colorado.
- There appears to be even somewhat clarity or planning in two of the biggest states that on 4 November 2020 went blue, New York and Pennsylvania. I’ve not seen statistics for doses shipped, but the results seem abysmally haphazard for planning, prioritizing, or jabs-per-vial. The caveat is those data are so closely held, perhaps the health departments know. But no one I ask does.
- Pennsylvania is particularly interesting. Per instructions from the state’s Health Secretary, with one key exception the vaccine’s distributors across the state are supposed to vaccinate health workers even if they are not associated with their specific hospital or system. Specifically there is to be a 10% set-aside for clinicians who do not have hospital affiliations. The key exception is Philadelphia, where there is a very large, very elaborate, very diverse and very managerial committee supposedly overseeing the distribution, negating the state’s otherwise 10% set-aside.
Informants in Philadelphia have seen no evidence that all this is working, with a Tower of Babel emerging instead. The state’s website is full of highly bureaucratic and highly prescriptive language about what to do. But probably because they’re simply overwhelmed, hospital officials, including MDs, seem to have given up on being proactive with communications or even answering e-mails. Unlike places like Massachusetts General and Stanford, many major department chairs in a preeminent institution are not yet vaccinated (personal communication). As of yesterday, 100k residents of Pennsylvania and New Jersey—very likely, I think, with New Jersey predominating per capita—since late December.
- In any case, it’s clear that in these states, where we’re told only “frontline health workers and nursing home residents and staff are currently eligible,” no one can really say that any of these words are true. It’s a black hole. But with a combined population of over 21M for the above two states, the uptake is less than 5%. Hey, a lot better than California, if we can believe what’s written above. (But these are all moving-target figures, so I’m not sure even I believe them.) It’s not bad. But in densely populated mid-Atlantic states, it’s still nowhere good enough. The numbers are too low and they’re inequitable when even health workers and immunocompromised patients aren’t getting vaccinated.
- Back to New York for just a moment. In a cleverly crafted distro, the media-savvy governor, Andrew Cuomo, said three weeks ago that
New York will begin vaccinating people with underlying health conditions as soon as late January, Gov. Andrew Cuomo said on Wednesday, as hundreds of thousands of vaccine doses are heading to the state in the coming weeks. The vaccination program is getting underway as the pandemic continues to surge in New York. The positive rate in the last day reached 6.21% out of 160,947 COVID-19 tests and 95 people died of the virus. There are now 6,097 people in the hospital due to COVID-19. But the vaccines are seen as the light at the end of the tunnel. New York is receiving nearly 170,000 doses of the COVID-19 vaccine from Pfizer and expects to receive 300,000 doses of a Moderna-manufactured vaccine in the coming weeks after its expected approval. Frontline health care workers and nursing home residents are scheduled to be vaccinated first. In the second phase, New Yorkers with underlying health conditions will be given the vaccine, which will be distributed by “regional hubs” led by health care networks on the local level. “It’s a medical procedure,” Cuomo said. “It will be handled by medical officials. There will be no political favoritism.” New York’s vaccination program will be conducted in multiple phases, with healthy adults and children going last. A vaccine program could run until September to reach a normal level of immunity in the country. The first non-clinical trial vaccines were administered this week in New York and the country. Plans for the second phase of the distribution program are due Jan. 1, Cuomo said. The goal, he added, is to make New York the first COVID-free state in the country.
It’s a week after January 1st. I find no evidence that this critical Phase 2 plan is anywhere in sight. Like Rachel Levine in Pennsylvania, lots of lofty “guiding principles,” but awfully hard in any well-defined way to see the boots on the ground. And the bootprints are running in circles.
- In Rhode Island the state’s DOH is falling far short of its responsibilities in terms of communicating with clinicians. One expert, highly placed in the national firmament of Internal Medicine, notes that exactly the same problems noted above for Pennsylvania, with unequal access, obtain in lower New England, with physicians having to resort to Facebook to look for communications. He notes thatThe DOH has fallen short in its communication with the provider community on what they should expect – ‘where’ and “how” – even if the “when” is murky because of frequently-changing delivery numbers. “Soon” and “we’re working on it” are not enough. Another unforced error, in my view, is the way they drew the distinction between physicians who are seeing COVID+ patients and those who are not (“high-risk” vs. “low-risk”). As a result, primary care physicians are in the 1d priority group, along with other types of workers, including “death professionals.” In a high-prevalence environment and with a virus that has a long pre-symptomatic infectious phase as well as a high percentage of asymptomatic infections, drawing such lines misses the point that all of us who have face-to-face contact with patients are at increased risk (especially if they are breathing, with all due respect to the funeral directors). [Italics mine.]
On the other hand, community clinicians can’t be expected to do the planning. They run on shoestring budgets. So round and round it goes, the circle of blame-shifting and planning deficits continues, and few get to know what’s going on in this part of New England. Wait: it sounds like the mid-Atlantic, a pattern appearing everywhere.
- Italy. Despite the vaunted construction of many design-forward, primrose-shaped (the COVID symbol in Italy) vaccine centers, distribution has been slow. One informant writes (my emphasis added) that
[h]ere in Italy the policy is set by the ministry of health, then the organization/implementation is of each region. As of now, but things are no doubt going to be reset going ahead, the first to be treated are the retirement homes (guests + employees working in contact with the guests) and the personnel of the public hospitals (doctors nurses cleaning etc.), then will be treated the family doctors, the elders +80 and the individuals which are fragile (i.e. those who would be at higher risk if they get the virus). The discussion is ongoing if the +80 and the fragile will be reached by the family doctors who would treat them at home if needed. Then will be treated the doctors+nurses+…. of the private hospitals. Discussion is ongoing about when to treat the dentists (and, I assume other similar categories). I think that, if this all will not become a nightmare, which is quite likely to happen, it will be our turn around April-May. [Italics mine.]
The government is organizing special vaccination gazebos which are being installed right now. Discussion is being raised about when to treat the inmates and it appears to be considered a priority because of the closed environment.I am asking myself what will be the approach about all those unable to decide for themselves. The individuals less than 16 won’t be treated for now (no vaccine exists yet here for them). As of now there is no obligation for anybody to get the treatment and as you may imagine there is a major discussion about this, at least for certain categories. In Italy there is in fact a substantial chunk of doctors-nurses-etc. refusing the treatment (from 10 to 30+%)….
Another informant from the same region wrote me that “[w]e hear that after doctors, nurses, first line health workers, people working in nursing homes, we shall start with vulnerable and people over 80 years old,” and on the same idea a WhatsApp message came through stating a typical Tuscan village’s “casa famiglia” had been that day fully vaccinated.
Why are the first- and hardest-hit in such continued difficulty? One informant writes that in Italy they have the “same questions here [as in US] about organization of this all (one of the problems here is of hiring new people, we seem to be late about that). We are very late with the organization, this is ridiculous, they had plenty of time to get organized!! Will see in the next weeks, they are working to overcome the problems. It will also depend from what is going to be the percentage of Pfizer, more difficult to handle. Also, it appears that there will be a shortage of vaccine, issue raised by Pfizer who urges the approval of other producers.”
-
France. For the entire world, but especially the European countries, a chart available from Oxford University’s superb Global Change Data Lab demonstrates how these countries’ efforts start up, stall out and scud along the x-axis with no proper, Israeli-style organizational accelerants. Slide the slider and you will see. Missing from the dataset entirely is France, whose Health Ministry just announced “a possible inscription [registration]” program [italics mine] for “those wanting to get vaccinated.” A Paris-based informant tells us in an e-mail that “[i]n France we will be vaccinated in another life.” Such exclamations of course reflect frustration as much as anything else, but for France the numbers really do seem dismal: Pfizer doses expected to be received by the nation at large are as follows (in millions): by 12/30/2020, 1.16. By 01/06/2021, another 0.68. On or around 02/19/2021, another 1.60. Paltry.
-
UK. Sort of a special case, because PH authorities in the UK are sort of like their current leader and arguably a big chunk of his followers: all over the map, even more than in the now-recovering US. My one respondent so far gives few numbers but notes uneasiness over lack of evidence for all the sleight-of-hand tricks being announced to alter dosage amounts and scheduling. A quick look at the above Oxford site, however, tells some of the story numerically. (The “daily doses administered” graph, with time-scale slider, is especially informative.) In the first three weeks of getting shots in arms, in the rolling 7-day average, Russia and Canada just slide along the bottom a nanometer above the horizontal axis; the UK scuds along, in parallel with them. somewhere just under 50k doses/day. That’s less than one one-thousandth of the population. Onward to 2024! And that’s with a National Health Service and an emphasis on primary care. Interestingly, the curve for the US, though nowhere nearly as impressive of that of Israel, does have a nice 45° slope, showing a zenith of about 350k doses per day. Oh, wait, if that levels off, it’s again on-to-2024. (But we can rely on a continued uptick, right? Right?)
-
Germany. I’ve received no response from German colleagues thus far. But the Oxford data puts Germany just above Croatia and below Canada. One plausible report from a day or two ago makes the following points based on data from the Robert Koch Institute. Just over a quarter million people have received COVID-19 vaccine in Germany as of January 4th, including more than 114,600 residents of nursing homes and around 123,100 medical staff. That’s only a week a half into the effort. “Germany has registered nearly 1.8 million coronavirus cases and about 35,000 [deaths]. The German government has emphasized that vaccines would be in short supply at the beginning and that it was necessary to prioritize. Citizens over 80 years of age as well as staff and residents of old people’s and nursing homes are among the first group to get inoculated. The first 1.3 million vaccine doses were delivered to Germany at the end of 2020. The government plans to distribute 670,000 vaccine doses every week from January 2021 onwards.